Protagonist Therapeutics Inc (PTGX)
Net Income
$162.85M
Quarterly · Period ending: · USD
PTGX Net Income
Latest reported$162.85Mperiod ending
Latest reported$162.85Mperiod ending
PTGX Quarterly Net Income (-$2.70M → $162.85M)
Quarterly net income
High-resolution chart · PNG
PTGX net income history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income (USD) |
|---|---|
| 162,849,000 | |
| 3,783,000 | |
| -44,384,000 | |
| -39,339,000 | |
| -34,771,000 | |
| -11,655,000 | |
| 131,674,000 | |
| -33,210,000 | |
| -30,616,000 | |
| 207,340,000 | |
| 27,335,000 | |
| -34,105,000 | |
| -38,460,000 | |
| -33,725,000 | |
| -34,194,000 | |
| -31,232,000 | |
| -41,037,000 | |
| -20,930,000 | |
| -36,907,000 | |
| -33,804,000 | |
| -30,842,000 | |
| -23,998,000 | |
| -18,886,000 | |
| -7,763,000 | |
| -19,421,000 | |
| -20,080,000 | |
| -17,501,000 | |
| -16,409,000 | |
| -29,174,000 | |
| -14,103,000 | |
| -13,865,000 | |
| -8,735,000 | |
| -8,663,000 | |
| -7,661,000 | |
| -3,052,000 | |
| -4,825,000 | |
| -14,979,000 | |
| -14,101,000 | |
| -11,248,000 | |
| -7,084,000 | |
| -7,098,000 | |
| -11,747,000 | |
| -5,493,000 | |
| -3,449,000 | |
| -3,219,000 | |
| -2,697,000 |